Episode 36: Sofinnova Invetments' Jim Healy
BioVenture VoiCes with Chris Garabedian
00:00
Sofinnova's focus on de-risked clinical stage deals
Jim describes the firm's bespoke strategy: invest mostly in clinical-stage, de-risked opportunities with clear paths.
Play episode from 28:27
Transcript
